Soft tissue sarcomas of childhood. Diagnosis and therapy;Weichteilsarkome im kindesalter. Diagnostik und therapie

Onkologe

Volumn 11, Issue 10, 2005, Pages 1047-1053

  Koscielniak, E ^a,d   Klingebiel, T ^b   Schuck, A ^c   Leuschner, I ^d  

^a OLGAHOSPITAL   (Germany)

^b UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^c UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^d Kindertumorregister Kiel ^*  (Germany)

Author keywords

Chemotherapy; Radiotherapy; Rhabdomyosarcoma; Soft tissue sarcoma; Surgery

Indexed keywords

ARTICLE; CHEMOTHERAPY; CHILD; CHILDHOOD; HISTOLOGY; HUMAN; MALIGNANT NEOPLASTIC DISEASE; PREOPERATIVE RADIOTHERAPY; PREOPERATIVE TREATMENT; PROGNOSIS; RHABDOMYOSARCOMA; SOFT TISSUE SARCOMA; SYNOVIAL SARCOMA; THERAPY; TUMOR VOLUME;

EID: 30444452385     PISSN: 09478965     EISSN: 14330415     Source Type: Journal    
DOI: 10.1007/s00761-005-0928-z     Document Type: Article

References (38)

1. Ackermann B, Tröger A, Glouchkova L, Körholz D, Göbel U, Dilloo D (2004) Characterization of CD34+ progenitor-derived dendritic cells pulsed with tumor cell lysate for a vaccination strategy in children with malignant solid tumors and a poor prognosis. Klin Pädiatr 216:176-182
2. Alava ED (2000) Molecular biology of the Ewing,s Sarcoma/primitive neuroectodermal tumor family. J Clin Oncol 18:204-213
3. Barr F (1997) Molecular genetics and pathogenesis of rahbdomyosarcoma. J Pediatr Hematol/Oncol 19:483-491
4. Bisogno G, Ferrari A, Bergeron C (2005) The IVADo regimen-A pilot study with ifosfamide, vincristine, actinomycin D, and doxorubicin in children with metastatic soft tissue sarcoma. Cancer 103:1719-1724
5. Bramwell V, Rouesse J, Steward W (1994) Adjuvant CYVADIC chemotherapy for adult soft tissue sarcoma-reduced local recurrence but no improvement in survival: a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group. J Clin Oncol 12:1137-1149
6. Breneman JC, Lyden E, Pappo AS (2003) Prognostic factors and clinical outcomes in children and adolescents with metastatic rhabdomyosarcoma - a report from the Intergroup Rhabdomyosarcoma Study IV. J Clin Oncol 21:78-84
7. Carli M, Colombatti R, Oberlin O (1999) High-dose melphalan with autologous stem-cell rescue in metastatic rhabdomyosarcoma. J Clin Oncol 17:2796-2803
8. Carli M, Passone E, Perilongo G, Bisogno G (2003) Ifosfamide in pediatric solid tumors. Oncology 65:99-104
9. Carli M, Sotti G, Alaggio R, Stevens MCG (2004) Soft Tissue Sarcomas. In: Pinkerton R PP, Pieters R, ed. Pediatric Oncology. London: Arnold
10. Carli M, Colombatti R, Oberlin O (2004) European intergroup studies (MMT4-89 and MMT4-91) on childhood metastatic rhabdomyosarcoma: final results and analysis of prognostic factors. J Clin Oncol 22:4787-4794
11. Coindre JM, Nguyen BB, Bonichon F, de Mascarel I, Trojani M (1988) Histopathologic grading in spindle cell soft tissue sarcomas. Cancer 61:2305-2309
12. Crist WM, Anderson JR, Meza JL (2001) Intergroup rhabdomyosarcoma study-IV: results for patients with nonmetastatic disease. J Clin Oncol 19:3091-3102
13. Crist W, Gehan EA, Ragab AH (1995) The Third Intergroup Rhabdomyosarcoma Study. J Clin Oncol 13:610-630
14. Joensuu H, Roberts PJ, Sarlomo-Rikala M (2001) Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor. N Engl J Med 344:1052-1056
15. Kampe CE, Rosen G, Eilber F (1994) Synovial sarcoma. A study of intensive chemotherapy in 14 patients with localized disease. Cancer 72:2161-2169
16. Kawaguchi S, Wada T, Ida K (2005) Phase I vaccination trial of SYT-SSX junction peptide in patients with disseminated synovial sarcoma. J Transl Med 3:1
17. Kawai A, Woodruff J, Healey JH, Brennan MF, Antonescu CR, Ladanyi M (1998) SYT-SSX gene fusion as a determinant of morphology and prognosis in synovial sarcoma. N Engl J Med 338:153-160
18. Koscielniak E, Dilloo D (2002) Definition of the high risk patients: the EBMT-CWS experience and CWS proposal for a therapeutic strategy for high risk sarcoma patients. Bone Marrow Transplant 30:33-34
19. Koscielniak E, Gross-Wieltsch U, Treuner J (2005) Graft-versus-Ewing sarcoma effect and long-term remission induced by haploidentical stem-cell transplantation in a patient with relapse of metastatic disease. J Clin Oncol 23:242-24419
20. Koscielniak E, Harms D, Henze G (1999) Results of treatment for soft tissue sarcoma in childhood and adolescence: a final report of the German Cooperative Soft Tissue Sarcoma Study CWS-86. J Clin Oncol 17:3706-3719
21. Koscielniak E, Klingebiel TH, Peters C (1997) Do patients with metastatic and recurrent rhabdomyosarcoma benefit from high-dose therapy with hematopoietic rescue? Report of the German/Austrian Pediatric Bone Marrow Transplantation Group. Bone Marrow Transplant 19:227-231
22. Koscielniak E, Rodary C, Flamant F (1992) Metastatic rhabdomyosarcoma and histologically similar tumors in childhood: a retrospective European multi-center analysis. Med Pediatr Oncol 20:209-214
23. Ladenstein R, Hartmann O, Koscielniak E, Philip T (2004) Megatherapy with stem cell rescue in solid tumors. In: Pinkerton R PP, Pieters R, ed. Paediatric Onclogy. London: Arnold; 539-569
24. Ladenstein R,Treuner J, Koscielniak E (1993) Synovial sarcoma of childhood and adolescence. Report of the German CWS-81 study. Cancer 71:3647-3655
25. Misawa A HH, Tsuchiya K, Iehara T, Sawada T, Sugimoto T (2003) Regression of refractory rhabdomyosarcoma after allogeneic stem-cell transplantation. Pediatr Hematol Oncol 151-15525
26. Newton WA Jr GE, Webber BL et al. (1995) Classification of rhabdomyosarcomas and related sarcomas. Pathologic aspects - an Intergroup Rhabdomysoarcoma Study. Cancer 76:1073-1085
27. Okcu MF, Despa S, Choroszy M (2001) Synovial sarcoma in children and adolescents: thirty three years of experience with multimodal therapy. Med Pediatr Oncol 37:90-96
28. Raney RB (2005) Synovial sarcoma in young people: background, prognostic factors, and therapeutic questions. J Pediatr Hematol Oncol 27:207-211
29. Rosen G, Forscher C, Lowenbraun S (1994) Synovial sarcoma. Uniform response of metastases to high dose ifosfamide. Cancer 73:2506-2511
30. Rubin BP, Schuetze SM, Eary JF (2002) Molecular targeting of platelet-derived growth factor B by imatinib mesylate in a patient with metastatic dermatofibrosarcoma protuberans. J Clin Oncol 20:3586-3591
31. Schramm A, Apostolov O, Sitek B, Pfeiffer K, Stühler K, Meyer HE, Havers W, Eggert A (2003) Proteomics: Techniques and applications in cancer research. Klin Pädiatr 215:293-297
32. Schulte JH, Schramm A, Pressel T, Klein-Hitpass L, Kremens B, Eils J, Havers W, Eggert A (2003) Microarray-analysis: A new approach to study the molecular mechanisms of thermo-chemotherapy. Klin Pädiatr 215:298-302
33. Siebenrock KA, Hertel R, Ganz R (2000) Unexpected resection of soft-tissue sarcoma. More mutilating surgery, higher local recurrence rates, and obscure prognosis as consequences of improper surgery. Arch Orthop Trauma Surg 120:65-69
34. Staege MS, Hattenhorst UE, Neumann I, Hutter C, Foja S, Burdach S (2003) DNA-Microarrays as tools for the identification of tumor specific gene expression profiles: Applications in tumor biology, diagnosis and therapy. Klin Pädiatr 215:135-138
35. Stegmeier S, Leuschner I, Aakcha-Rudel E, Münch P, Kazanowska B, Bekassy A, Treuner J, Koscielniak E (2004) Identification of various exon combinations of the ews/fli1 translocation: An optimized PT-PCR method for paraffin embedded tissue. A report by the CWS-Study Group. Klin Pädiatr 216:315-322
36. Stevens MC, Rey A, Bouvet N (2005) Treatment of nonmetastatic rhabdomyosarcoma in childhood and adolescence: third study of the International Society of Paediatric Oncology-SIOP Malignant Mesenchymal Tumor 89. J Clin Oncol 23:2618-2628
37. Treuner J (2003) Interim Report of the CWS-96 Study: Results of the tretament for soft tissue sarcomas in childhood
38. Wessalowski R, Schneider DT, Mils O et al. (2003) An approach for cure: PEI-chemotherapy and regional deep hyperthermia in children and adolescents with unresectable malignant tumors. Klin Pädiatr 215:303-309